Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-08

Study Completion Date

2025-06-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. Sensitivity and specificity of cranial neuromuscular US to detect the prognosis of Guillain Barre Syndrome
2. Correlation of US values with motor, respiratory and autonomic complications of Guillain Barre Syndrome

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome

NCT04053452

Guillain-Barre Syndrome

TERMINATED NA

Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome

NCT04927598

Guillain-Barre Syndrome

COMPLETED

Early and Late Prognosis in Patients With Guillain-Barre Syndrome

NCT06041451

Guillain-Barre Syndrome

UNKNOWN PHASE4

Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome

NCT04829526

Guillain-Barre Syndrome (GBS)

RECRUITING

Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.

NCT01024088

Tetraplegia Respiratory Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Guillain-Barré syndrome (GBS) is a dangerous and under certain circumstances life-threatening immune-mediated polyneuropathy of acute onset, often subsequent to respiratory or diarrheal illness. Patients usually present with distal onset of slight sensory symptoms such as numbness and tingling followed by ascending weakness of arms and legs, often involving cranial nerves Typical clinical findings are symmetric, flaccid paresis, reduced or absent deep tendon reflexes, and slight sensory symptoms only. Many variants of GBS such as pharyngeal-brachial or bulbar variants exist; the Miller-Fisher syndrome (MFS) with ataxia, areflexia, and oculomotor dysfunction; or the Elsberg syndrome with accentuated involvement of the autonomic nervous system. Diagnosis of GBS is normally based on typical clinical onset, laboratory findings, and electrophysiological studies.

In literature, Campylobacter jejuni infection is the most commonly identified precipitant of GBS. Cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus (HIV), and Zika virus have also been reported with GBS \[5\]. A small percentage of patients develop GBS after other triggering events such as immunization, surgery, trauma, and bone-marrow transplantation.

Autonomic dysfunction (AD) in GBS predominantly occurs in the acute phase of the illness but can manifest in the recovery phase too. The exact mechanism remains unknown but probably involves dysfunction in the sympathetic and parasympathetic systems \[8\].

AD in GBS is observed in 70% of the cases \[7\]; features including tachycardia, bradycardia, facial flushing, hypertension alternating with hypotension, orthostatic hypotension, anhydrosis or diaphoresis, and urinary retention while gastrointestinal autonomic manifestation includes diarrhea or constipation \[9\]. Severe autonomic dysfunction is an important factor to recognize and treat accordingly as this is occasionally associated with a sudden death rate of 5-7% \[10,11\].

Guillain-Barré Syndrome (GBS) is often accompanied by respiratory failure that necessitates mechanical ventilation (MV).1 About 20-30% of cases require respiratory support.2-4 Major complications, including pulmonary infections, sepsis and pulmonary embolism, are reported in 60% of intubated patients with GBS.5, 6 The worldwide mortality rate for ventilated patients ranges from 15% to 30%, with survivors usually having poor outcomes.7 . Multiple clinical and biological parameters have been identified as risk factors for impending respiratory failure in GBS,9, 10 including cranial nerve involvement, disability grade on admission, rapidly progressive motor weakness, an absence of deep tendon reflexes, autonomic dysfunction, and features of nerve conduction block on electromyography.11-14

Facial nerve is commonly involved in GBS, occurring in at least half of patients. Other cranial nerves like bulbar nerves, abducent, oculomotor, optic, hypoglossal nerves are less often affected Ultrasound (US) is a reliable, effective, noninvasive, and well tolerated technique that allows multiple nerves to be examined in a relatively short period. Ultrasound (US) studies have demonstrated patchy enlargement of cranial nerves in Guillain-Barré syndrome (GBS). However, whether ultrasound yields useful information for early classification of GBS has not been established. We aimed to evaluate nerve ultrasound in patients with GBS in assuit university hospital. As confirmed in acquired immune-mediated neuropathies and inherited demyelinating neuropathies peripheral nerves can exhibit quantifiable enlargement in increased cross-sectional areas (CSA).

We follow up the patient to see improvement and accordingly we see the predictive value of neuromuscular ultrasound of cranial nerves in Guillain-Barré syndrome

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Guillain-Barre Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Guillain-Barré syndrome patients

neuromuscular ultrasound of cranial nerves

Intervention Type DEVICE

neuromuscular ultrasound of cranial nerves.

normal participants

neuromuscular ultrasound of cranial nerves

Intervention Type DEVICE

neuromuscular ultrasound of cranial nerves.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

neuromuscular ultrasound of cranial nerves

neuromuscular ultrasound of cranial nerves.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients fulfilling the diagnostic criteria of GBS within the first 2 weeks.
* Age: 18-65
* Both sexes

Exclusion Criteria

* Past history of previous similar condition or history suggestive of CIDP.
* Any proved alternative diagnosis like hypo- or hyperkalemic paralysis, porphyria, or myositis.
* Other possible causes of peripheral neuropathy, diabetes, renal, and other metabolic disorders.
* History of Autonomic or cardiopulmonary dysfunction before the onset of symptoms.
* Patients who refused to participate or sign an informed consent.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes